The surgical stents market has seen significant growth due to the increasing prevalence of chronic diseases such as cardiovascular, respiratory, and urinary disorders. Stents are critical devices used to support and open blocked arteries or other bodily tubes during surgical procedures. The market is primarily driven by the rising aging population, the growing number of surgeries, and advancements in stent technology. Advancements in surgical stents have significantly improved their efficacy, safety, and patient outcomes. New-generation drug-eluting stents (DES), for instance, are designed to release medication that prevents restenosis (the re-narrowing of arteries), reducing the risk of complications. Biodegradable stents are another advancement, which dissolve over time, eliminating the need for a second procedure to remove them. Innovations in materials, such as the use of bioabsorbable polymers, have also improved stent performance, reducing adverse reactions and enhancing compatibility with the human body. The market faces challenges, including the high cost of advanced stents and risks associated with implantation, such as infection or thrombosis. Despite these challenges, ongoing research and the demand for minimally invasive procedures are expected to continue driving growth in the surgical stents market.
